# DESCRIPTION

- claim priority to provisional application

## FIELD OF THE INVENTION

- introduce corneal endothelial cells generation

## BACKGROUND

- describe corneal endothelium function and diseases

## SUMMARY

- summarize generation of clinical-grade corneal endothelial cells
- describe method of producing corneal endothelial cells
- outline culturing and differentiating steps
- identify matured corneal endothelial cells
- describe method of preventing or treating corneal diseases
- outline reprogramming method for producing induced pluripotent stem cells

## DETAILED DESCRIPTION

- introduce conical endothelial cells (CECs) from human embryonic stem cells (hESCs) and peripheral blood mononuclear cell (PB
- describe human embryonic stem cells (hESCs) and their potential in regenerative medicine
- describe human induced pluripotent stem cells (iPSCs) and their advantages
- outline method of producing corneal endothelial cells (CECs) from iPSCs and hESCs
- describe corneal endothelium and its importance in maintaining corneal transparency
- discuss corneal diseases and associated disorders, including Fuchs endothelial corneal dystrophy (FECD) and keratoconus
- outline methods of treatment for corneal associated diseases or disorders using CECs
- describe compositions comprising CECs and their therapeutic applications
- discuss isolation and preparation of cells from peripheral blood mononuclear cells (PBMCs) and other sources
- outline kits comprising pharmaceutical compositions and CECs for therapeutic use

### EXAMPLES

- report derivation and cryopreservation of clinical-grade corneal endothelial cells
- describe materials and methods for isolation and cryopreservation of peripheral blood mononuclear cells
- detail generation of induced pluripotent stem cells using Sendai-virus delivery system
- characterize induced pluripotent stem cells by flow cytometry and quantitative real-time polymerase chain reaction
- describe differentiation of induced pluripotent stem cells and human embryonic stem cells into corneal endothelial cells
- characterize human embryonic stem cell- and induced pluripotent stem cell-derived corneal endothelial cells by quantitative real-time PCR and immunocyto
- perform RNA-Seq analysis of non-cryopreserved and cryopreserved human embryonic stem cell-derived corneal endothelial cells
- describe rabbit injection model
- describe monkey injection model
- evaluate clinical and histological outcomes
- generate and validate iPSCs
- differentiate iPSCs and hESCs into CECs
- validate cryopreserved CECs
- discuss results and implications

## EQUIVALENTS

- acknowledge equivalents

